New drug trial aims to tame sudden sleep attacks
NCT ID NCT07363720
Summary
This study is testing if an investigational drug called TAK-861 can effectively control the symptoms of narcolepsy type 1, a sleep disorder that causes severe daytime sleepiness and sudden muscle weakness (cataplexy). About 88 participants worldwide will take the drug for several months, and then some will be randomly switched to a placebo for up to 4 weeks to see if their symptoms return. The main goal is to see if the drug's effect on keeping people awake and reducing cataplexy is maintained over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NARCOLEPSY TYPE 1 (NT1) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Takeda Site 1
RECRUITINGRedwood City, California, 94063, United States
-
Takeda Site 2
RECRUITINGCincinnati, Ohio, 45245, United States
-
Takeda Site 3
RECRUITINGColumbia, South Carolina, 29201, United States
-
Takeda Site 4
RECRUITINGBrandon, Florida, 33511, United States
-
Takeda Site 5
RECRUITINGAustin, Texas, 78731, United States
-
Takeda Site 6
RECRUITINGMiami, Florida, 33155, United States
-
Takeda Site 7
RECRUITINGSouthfield, Michigan, 48075, United States
Conditions
Explore the condition pages connected to this study.